DOPPELIB
LIVE

Serial Number

99080255

Owner

CHIOME BIOSCIENCE INC.

Attorney

Jeffrey H. Handelsman

Filing Date

Mar 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DOPPELIB Trademark

Serial Number: 99080255

DOPPELIB is a trademark filed by CHIOME BIOSCIENCE INC. on March 12, 2025. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

CHIOME BIOSCIENCE INC.

3-12-1, Honmachi, Shibuya-ku,
Tokyo 1510071 , JP

Entity Type: 03

Trademark Details

Filing Date

March 12, 2025

Registration Date

Not Registered

Goods & Services

Product research and development services for others in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Quality management services, namely, quality control in the fields of proteins, antibodies, microorganisms and cells for medical use and consultancy relating thereto; Research and development services in the field of antibody development technology; Research and development services in the field of antibody technology; Biomedical research services; Design and development of medical technology; Research and development in the field of biotechnology; Pharmaceutical research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical preparations; Scientific research in the nature of conducting clinical trials for others; Technical research services, namely, conducting technical project studies in the field of antibody development technology; Technical research in the field of antibody development technology; Engineering services, particularly technical project planning in the field of antibody development technology; Research and development of new products for others; Design and development of computer software for use with medical technology; Software design and development; Rental of computer software for use with medical technology; Providing temporary use of on-line non-downloadable software for use with medical technology; Providing virtual computer systems through cloud computing; Scientific laboratory services relating to the acquisition, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies; Scientific laboratory services relating to the screening, isolation and cultivation of antibodies, namely, antibodies or antibody-producing cells with desired properties from a population of cells that produce various antibodies, or the acquisition of antibodies or antibody-producing cells with desired properties; Provision of cell lines for scientific and medical research and development; Provision of antibodies for scientific and medical research and development

Biomanufacturing for others, namely, contract-based purification of antibodies; Biomanufacturing for others, namely, selection and purification of antibodies; Biomanufacturing for others, namely, selection and purification of proteins; Custom manufacturing of cell lines for laboratory, research and development, or medical purposes; Custom manufacturing of cell lines for antibody production; Custom manufacturing of cell lines; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues for medical, laboratory, or research and development purposes; Biomanufacturing for others, namely, biomanufacturing of biological cultured tissues; Biomanufacturing for others, namely, contract-based biomanufacturing of biological preparations in the nature of proteins; Processing of biological pharmaceutical preparations for others; Treatment of biological pharmaceutical preparations for others; Biomanufacturing for others, namely, selection and purification of biological preparations in the nature of proteins; Contract-based biomanufacturing in the field of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceuticals; Biomanufacturing for others, namely, selection and purification of pharmaceutical preparations; Cryogenic preservation of biological tissues; Custom manufacturing of dietary supplements for humans; Food processing; Dietetic food and drink processing; Preservation of antibodies for scientific and medical research and development

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 24, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 24, 2026 CRFA
ASSIGNED TO LIE
Feb 24, 2026 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 18, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 29, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 29, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 29, 2025 CNSL
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Dec 4, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Dec 4, 2025 PARI
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 13, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 12, 2025 MAFR
NEW APPLICATION ENTERED
Mar 12, 2025 NWAP